First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.2292 USD 6.11% Market Closed
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

3.9m
-35%
Assets
Growth Rates:
1 Year
-52%
3 Years
-73%
5 Years
-70%
7 Years
-63%
10 Years
-85%
6.4m
+12%
Liabilities
Growth Rates:
1 Year
+73%
3 Years
+28%
5 Years
-12%
7 Years
+45%
10 Years
+1%
-2.5m
Equity
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Yield10 Bioscience Inc

3.9m
Assets
6.4m
Liabilities
3.9m
Assets
6.4m
Liabilities
Current Assets 1.4m
Cash & Short-Term Investments 1.1m
Other Current Assets 332k
Non-Current Assets 2.5m
PP&E 2.2m
Other Non-Current Assets 306k
Current Liabilities 4.9m
Accounts Payable 1.2m
Accrued Liabilities 2.7m
Other Current Liabilities 984k
Non-Current Liabilities 1.5m
Other Non-Current Liabilities 1.5m

Balance Sheet
Yield10 Bioscience Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
20
12
7
15
3
5
3
5
2
1
Cash Equivalents
20
12
7
15
3
5
3
5
2
1
Short-Term Investments
0
0
0
0
3
6
6
11
2
0
Total Receivables
1
1
0
0
0
0
0
0
0
0
Accounts Receivables
1
1
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1
0
0
0
0
0
0
0
0
0
Other Current Assets
1
2
0
0
0
1
1
0
1
0
Total Current Assets
22
15
8
15
6
12
10
17
5
1
PP&E Net
1
0
2
2
6
4
4
3
3
2
PP&E Gross
0
0
2
2
0
4
4
3
3
2
Accumulated Depreciation
0
3
2
2
0
2
1
1
1
2
Other Long-Term Assets
1
2
1
0
0
1
1
1
0
0
Total Assets
23
N/A
17
-26%
11
-37%
17
+58%
13
-23%
17
+28%
15
-13%
20
+41%
8
-60%
4
-52%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
0
0
1
Accrued Liabilities
4
4
3
2
2
2
2
2
2
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
1
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
4
4
3
2
2
2
2
2
2
5
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
2
1
6
19
3
3
2
2
Total Liabilities
4
N/A
4
-5%
4
+7%
3
-23%
7
+115%
21
+185%
5
-76%
4
-12%
4
-16%
6
+73%
Equity
Common Stock
0
0
0
1
0
0
0
0
0
0
Retained Earnings
302
326
333
343
352
365
375
386
400
414
Additional Paid In Capital
321
339
340
355
358
361
385
402
404
412
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
19
N/A
13
-31%
6
-51%
14
+111%
6
-58%
4
N/A
10
N/A
16
+68%
4
-73%
2
N/A
Total Liabilities & Equity
23
N/A
17
-26%
11
-37%
17
+58%
13
-23%
17
+28%
15
-13%
20
+41%
8
-60%
4
-52%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
1
3
5
5
12
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Summary
YTEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
YTEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
YTEN stock valuation using valuation multiples.
Wall Street Estimates
YTEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
YTEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.